Korro Bio is trading at $12.85, up 8.90%, after no verified company-specific announcement was identified for September 18, 2026.
- The latest identified disclosure was a September 11 inducement grant covering 5,000 stock options, which does not explain the pre-market gain.
- Broader futures are mixed, so no clear macro catalyst is confirmed. Confidence remains low.